The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant S-1 plus cisplatin-based chemoradiotherapy compared with surgery alone for locally advanced gastric cancer: Randomized, phase II trial.
 
Moonki Hong
No Relationships to Disclose
 
Kum-Hee Yun
No Relationships to Disclose
 
Minkyu Jung
Employment - Ensol Biosciences (I)
Stock and Other Ownership Interests - Ensol Biosciences; Ensol Biosciences (I)
Honoraria - Celltrion; Lilly
 
Sun Young Rha
Consulting or Advisory Role - Aadi; Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; Eutilex; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical; Toray Industries
Speakers' Bureau - Amgen; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks
 
Hyoung-Il Kim
No Relationships to Disclose
 
Jun Chul Park
No Relationships to Disclose
 
Sang Kil Lee
No Relationships to Disclose
 
Seo Hee Choi
No Relationships to Disclose
 
Inkyung Jung
No Relationships to Disclose
 
Joon Seok Lim
No Relationships to Disclose
 
Woo Jin Hyung
Employment - Hutom
Leadership - Hutom
Stock and Other Ownership Interests - Hutom
Research Funding - GC Pharma; Medtronic
 
Woong Sub Koom
No Relationships to Disclose
 
Hyo Song Kim
No Relationships to Disclose